Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis
出版年份 2015 全文链接
标题
Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis
作者
关键词
Infliximab, Rheumatoid Arthritis Patient, Adalimumab, Tocilizumab, Omalizumab
出版物
CLINICAL PHARMACOKINETICS
Volume 54, Issue 11, Pages 1107-1123
出版商
Springer Nature
发表日期
2015-06-28
DOI
10.1007/s40262-015-0296-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tumor Necrosis Factor-Alpha Antagonists: Differential Clinical Effects by Different Biotechnological Molecules
- (2017) F. Licastro et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Pharmacokinetics and concentration-effect relationship of adalimumab in rheumatoid arthritis
- (2015) David Ternant et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A pharma perspective on the systems medicine and pharmacology of inflammation
- (2015) Julio Lahoz-Beneytez et al. MATHEMATICAL BIOSCIENCES
- Development of a Population PK Model of Tacrolimus for Adaptive Dosage Control in Stable Kidney Transplant Patients
- (2015) Franc Andreu et al. THERAPEUTIC DRUG MONITORING
- The Comparative Safety of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta-analysis Update of 44 Trials
- (2014) Tzeyu L. Michaud et al. AMERICAN JOURNAL OF MEDICINE
- Towards an individualised target concentration of adalimumab in rheumatoid arthritis
- (2014) Emilie Ducourau et al. ANNALS OF THE RHEUMATIC DISEASES
- Pegylation of Biological Molecules and Potential Benefits: Pharmacological Properties of Certolizumab Pegol
- (2014) Gianfranco Pasut BIODRUGS
- Therapeutic drug monitoring of once daily aminoglycoside dosing: comparison of two methods and investigation of the optimal blood sampling strategy
- (2014) Lana Nezic et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Monoclonal antibody disposition: a simplified PBPK model and its implications for the derivation and interpretation of classical compartment models
- (2014) Ludivine Fronton et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Vancomycin Monitoring in Children Using Bayesian Estimation
- (2014) Jennifer Le et al. THERAPEUTIC DRUG MONITORING
- Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease
- (2013) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Key findings towards optimising adalimumab treatment: the concentration–effect curve
- (2013) Mieke F Pouw et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation
- (2013) Pauline A van Schouwenburg et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab-Induced T Cell Depletion in Patients With Rheumatoid Arthritis: Association With Clinical Response
- (2013) J. Mélet et al. ARTHRITIS AND RHEUMATISM
- The combined use of disease activity and infliximab serum trough concentrations for early prediction of (non-)response to infliximab in rheumatoid arthritis
- (2013) Bart J. F. van den Bemt et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis
- (2013) David Ternant et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A systems biology approach to suppress TNF-induced proinflammatory gene expressions
- (2013) Kentaro Hayashi et al. Cell Communication and Signaling
- Pharmacokinetics and Safety of Golimumab in Healthy Chinese Subjects Following a Single Subcutaneous Administration in a Randomized Phase I Trial
- (2013) Yanli Zhuang et al. CLINICAL DRUG INVESTIGATION
- Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies
- (2013) Miroslav Dostalek et al. CLINICAL PHARMACOKINETICS
- Modeling approach to investigate the effect of neonatal Fc receptor binding affinity and anti-therapeutic antibody on the pharmacokinetic of humanized monoclonal anti-tumor necrosis factor-α IgG antibody in cynomolgus monkey
- (2013) Chee M. Ng et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab
- (2013) Bella Ungar et al. GUT
- Pharmacokinetics and pharmacodynamics of single subcutaneous doses of tocilizumab administered with or without rHuPH20
- (2013) Peter N. Morcos et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Mechanism-based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study)
- (2013) Shuji Ohta et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Biologic therapies and pregnancy: the story so far
- (2013) K. L. Hyrich et al. RHEUMATOLOGY
- The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases
- (2013) M. Jani et al. RHEUMATOLOGY
- Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy
- (2013) Kanae Tani et al. RHEUMATOLOGY INTERNATIONAL
- Low- Versus High-Dose Rituximab for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2013) Markus Bredemeier et al. ARTHRITIS CARE & RESEARCH
- The Utility of Modeling and Simulation Approaches to Evaluate Immunogenicity Effect on the Therapeutic Protein Pharmacokinetics
- (2012) Juan Jose Perez Ruixo et al. AAPS Journal
- The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis
- (2012) Sandra Garcês et al. ANNALS OF THE RHEUMATIC DISEASES
- Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
- (2012) Uma Mahadevan et al. Clinical Gastroenterology and Hepatology
- Therapeutic Drug Monitoring of Imatinib
- (2012) Verena Gotta et al. CLINICAL PHARMACOKINETICS
- Local versus Systemic Anti-Tumour Necrosis Factor-α Effects of Adalimumab in Rheumatoid Arthritis
- (2012) David Stepensky CLINICAL PHARMACOKINETICS
- Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms
- (2012) I Ordás et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Lessons from mathematically modeling the NF-κB pathway
- (2012) Soumen Basak et al. IMMUNOLOGICAL REVIEWS
- Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Biologic Therapy
- (2012) Maria A. Lopez-Olivo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lifespan based indirect response models
- (2012) Wojciech Krzyzanski et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice
- (2012) Jaclyn Anderson et al. ARTHRITIS CARE & RESEARCH
- Multi-Scale In Vivo Systems Analysis Reveals the Influence of Immune Cells on TNF-α-Induced Apoptosis in the Intestinal Epithelium
- (2012) Ken S. Lau et al. PLOS BIOLOGY
- American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
- (2011) David T. Felson et al. ARTHRITIS AND RHEUMATISM
- Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study
- (2011) Bart JF van den Bemt et al. BMC MUSCULOSKELETAL DISORDERS
- Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis
- (2011) David Ternant et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets
- (2011) Pauline L Martin et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacokinetic Properties of Infliximab in Children and Adults with Crohn's Disease: A Retrospective Analysis of Data from 2 Phase III Clinical Trials
- (2011) Adedigbo A. Fasanmade et al. CLINICAL THERAPEUTICS
- Population pharmacokinetics of golimumab in patients with ankylosing spondylitis: impact of body weight and immunogenicity
- (2011) Z.H. Xu et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Development of a new immunoassay for the accurate determination of anti-infliximab antibodies in inflammatory bowel disease
- (2011) Hirotsugu Imaeda et al. JOURNAL OF GASTROENTEROLOGY
- Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach
- (2011) Leonid Gibiansky et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors
- (2011) Regina Rendas-Baum et al. ARTHRITIS RESEARCH & THERAPY
- Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases
- (2011) Emilie Ducourau et al. ARTHRITIS RESEARCH & THERAPY
- Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint
- (2010) Stephen B. Duffull et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Nathanael L. Dirks et al. CLINICAL PHARMACOKINETICS
- Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testing
- (2010) Kay Stubenrauch et al. CLINICAL THERAPEUTICS
- Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases
- (2010) Peter C Taylor CURRENT OPINION IN PHARMACOLOGY
- Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis
- (2010) Nicolas Frey et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Population Approach for Exposure-Response Modeling of Golimumab in Patients With Rheumatoid Arthritis
- (2010) Chuanpu Hu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A novel method for the detection of antibodies to adalimumab in the presence of drug reveals “hidden” immunogenicity in rheumatoid arthritis patients
- (2010) Pauline A. van Schouwenburg et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials
- (2010) L. Campbell et al. RHEUMATOLOGY
- Theory-based analysis of anti-inflammatory effect of infliximab on Crohn’s disease and rheumatoid arthritis
- (2010) Koji Kimura et al. RHEUMATOLOGY INTERNATIONAL
- The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: a review
- (2010) Charlotte Krieckaert et al. ARTHRITIS RESEARCH & THERAPY
- Biodistribution Mechanisms of Therapeutic Monoclonal Antibodies in Health and Disease
- (2009) Mohammad Tabrizi et al. AAPS Journal
- Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis
- (2009) R M Thurlings et al. ANNALS OF THE RHEUMATIC DISEASES
- A Pharmacodynamic Markov Mixed-Effects Model for Determining the Effect of Exposure to Certolizumab Pegol on the ACR20 Score in Patients With Rheumatoid Arthritis
- (2009) B D Lacroix et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
- (2009) Adedigbo A. Fasanmade et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic–pharmacodynamic modeling of biologics
- (2009) Leonid Gibiansky et al. Expert Opinion on Drug Metabolism & Toxicology
- Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
- (2009) Konstantinos Karmiris et al. GASTROENTEROLOGY
- Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis
- (2009) Denis Mulleman et al. ARTHRITIS RESEARCH & THERAPY
- Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis
- (2008) T R D J Radstake et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
- (2008) C Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- Golimumab, a human antibody to tumour necrosis factor given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
- (2008) E C Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Population Pharmacokinetics of Infliximab in Patients With Ankylosing Spondylitis
- (2008) Zhenhua Xu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Approximations of the target-mediated drug disposition model and identifiability of model parameters
- (2008) Leonid Gibiansky et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now